Etodolac Tablet, Film Coated, Extended Release
FDA Label NDC 65841-777

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Etodolac (NDC 65841-777). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-777-14 in bottle of 60 tablets

Etodolac Extended-release Tablets USP, 400 mg

Rx only

60 tablets

Etodolac Extended-release Tablets Usp, 400 mg (3f65753d 4399 44ea 8b40 16eaae29d3be 01)

Etodolac Extended-release Tablets Usp, 400 mg (3f65753d 4399 44ea 8b40 16eaae29d3be 01)

NDC 65841-778-14 in bottle of 60 tablets

Etodolac Extended-release Tablets USP, 500 mg

Rx only

60 tablets

Etodolac Extended-release Tablets Usp, 500 mg (3f65753d 4399 44ea 8b40 16eaae29d3be 02)

Etodolac Extended-release Tablets Usp, 500 mg (3f65753d 4399 44ea 8b40 16eaae29d3be 02)

NDC 65841-779-14 in bottle of 60 tablets

Etodolac Extended-release Tablets USP, 600 mg

Rx only

60 tablets

Etodolac Extended-release Tablets Usp, 600 mg (3f65753d 4399 44ea 8b40 16eaae29d3be 03)

Etodolac Extended-release Tablets Usp, 600 mg (3f65753d 4399 44ea 8b40 16eaae29d3be 03)

* Please review the disclaimer below.